IRE ELiT and ROTOP Pharmaka, two innovative radiopharmaceuticals companies focused on diagnostics and therapeutics have recently announced that they have entered into an exclusive commercial agreement for the distribution of Galli Ad (the 68Ge/68Ga generator from IRE ELiT) in Germany.
This strategic decision is an important step to increase the presence of Galli Ad generators in Germany, representing the leading market in Europe for Gallium-68 development.
The switch over from distributorship will be effective in early 2021, with total continuity of supply and support to their current customers.
To read more please visit:
Source: IRE ELiT